Finance

Lists
DIVISLAB:NSE
Divi's Laboratories Ltd
₹8,281.50
+0.08%
(+6.50) 1D
Aug 10, 2:23:08 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for DIVISLAB...
Open
₹8,285.00
High
₹8,350.00
Low
₹8,258.50
Mkt. cap
2.20T
Avg. vol.
0.00
Volume
299.16K
Dividend
0.36%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
75.13
52-wk high
₹8,585.00
52-wk low
₹5,636.50
EPS
₹110.20
Shares outstanding
265.47M
No. of employees
12K
Open
₹8,285.00
High
₹8,350.00
Low
₹8,258.50
Mkt. cap
2.20T
Avg. vol.
0.00
Volume
299.16K
Dividend
0.36%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
75.13
52-wk high
₹8,585.00
52-wk low
₹5,636.50
EPS
₹110.20
Shares outstanding
265.47M
No. of employees
12K
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd
CEOKiran S. Divi
Employees11.6K
FoundedOct 12, 1990
Headquarters-
SectorHealth care
Websitedivislabs.com
Last report
Aug 1, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹33.95 / ₹24.68
+37.58%beat
Revenue / Est. (INR)
30.80B / 27.61B
+11.56%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
27.15B
26.04B
28.31B
30.80B
Cost of goods sold
10.73B
9.45B
13.49B
9.86B
Cost of revenue
10.73B
9.45B
13.49B
9.86B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.54B
3.67B
3.99B
4.08B
Operating expense
8.67B
8.87B
6.68B
9.65B
Total operating expenses
19.40B
18.32B
20.17B
19.51B
Operating income
7.75B
7.72B
8.14B
11.29B
Other non operating income
820.00M
690.00M
-2.23B
640.00M
EBT including unusual items
9.12B
7.80B
9.63B
11.80B
EBT excluding unusual items
9.12B
8.54B
9.59B
11.80B
Income tax expense
2.23B
1.97B
2.12B
2.78B
Effective tax rate
24.45%
25.26%
22.01%
23.56%
Other operating expenses
4.00B
4.02B
1.49B
4.24B
Net income
6.89B
5.83B
7.51B
9.02B
Net profit margin
25.38%
22.39%
26.53%
29.29%
Earnings per share
25.97
24.07
28.31
33.95
Interest and investment income
-
-
2.84B
-
Interest expense
-80.00M
-60.00M
-60.00M
-60.00M
Net interest expenses
-80.00M
-60.00M
2.78B
-60.00M
Depreciation and amortization charges
1.13B
1.18B
1.20B
1.33B
EBITDA
8.88B
8.72B
9.29B
12.44B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps